Idiopathic pulmonary fibrosis
RecruitingPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
- Disease:Idiopathic pulmonary fibrosis
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Germany92 clinical trials in Witten, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on psoriasis treatments and advanced therapies for atopic dermatitis. Studies evaluate novel medications for managing chronic skin conditions and improving patient outcomes.
Multiple trials examining both systemic and targeted therapies for moderate to severe skin conditions.
Comprehensive research into asthma and COPD treatments, including studies on new inhalation devices and combination therapies. Trials also focus on respiratory syncytial virus prevention in different age groups.
Emphasis on improving lung function and reducing exacerbations in chronic respiratory conditions.
Groundbreaking research in breast cancer treatment, particularly focusing on hormone receptor-positive cases. Studies include innovative approaches to colon cancer management.
Trials investigating both neoadjuvant and adjuvant treatment strategies in various cancer types.
Tell us about your condition – we search every trial in Europe and connect you with the right site.